HSV: Persistence in the population: Epidemiology, transmission

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 656-672

  Wald, Anna ^a   Corey, Lawrence ^b  

^a Virology Research Clinic   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859430779     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.037     Document Type: Chapter

References (166)

1. Alster, T. S. and Nanni, C. A. (1999). Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol. Surg, 25, 242-246.
2. Amir, J., Harel, L., Smetana, Z., and Varsano, I. (1999). The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatr. Dermatol., 16, 259-263.
3. Anderson, B. J. (1999). The effectiveness of valacyclovir in prevent-ing reactivation of herpes gladiatorum in wrestlers. Clin. J. Sport Med., 9, 86-90.
4. Anderson, B. J. (2003). The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. Med. Sci. Sports Exerc., 35, 1809-1814.
5. Aoki, F. Y., Tyring, S., Diaz-Mitoma, F., Gross, G., Gao, J. and Hamed, K. (2006). Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: A randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis., 42(1), 8-13.
6. Arvin, A., Yeager, A., Bruhn, F., and Grossman, M. (1982). Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J. Pediatrics, 100, 715-721.
7. Arvin, A., Hensleigh, P., Prober, C. etal. (1986). Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N. Engl. J. Med., 315, 796-800.
8. Austin, H., Macaluso, M., Nahmias, A. et al. (1999). Correlates of herpes simplex virus seroprevalence among women attend-ing a sexually transmitted disease clinic. Sex Transm. Dis., 26, 329-334.
9. Bagdades, E., Pillay, D., Squire, S., O'Neil, C., Johnson, M., and Grifths, P. (1992). Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS, 6, 1317-1320.
10. Balfour H. (1994). Recurrent ocular herpes simplex infection. Pedi-atr. Infect. Dis. J., 13, 170.
11. Ballard R. (2001). In ASHA Summit on HSV Diagnostics Seattle.
12. Barton, S. E., Davis, J. M., Moss, V. W., Tyms, A. S., and Munday, P. E. (1987). Asymptomatic shedding and subsequent transmission of genital herpes simplex virus. Genitourin. Med., 63, 102-105.
13. Becker, T. M. (1992). Herpes gladiatorum: A growing problem in sports medicine. Cutis, 50, 150-152.
14. Beeson, W. H. and Rachel, J. D. (2002). Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence follow-ing laser skin resurfacing. Dermatol Surg., 28, 331-336.
15. Bell, W., Chulay, J., and Feinberg, J. (1997). Manifestations resem-bling thrombotic microangiopathy in patients with advanced HIV disease in a cytomegalovirus prophylaxis trial (ACTG 204). Medicine, 76, 369-380.
16. Belongia, E., Goodman, J., Holland, E. et al. (1991). An outbreak of herpes gladiatorum at a high school wrestling camp. N. Engl. J. Med., 325, 906-910.
17. Benedetti, J. K., Corey, L., and Ashley, R. (1994). Recurrence rates in genital herpes after symptomatic rst-episode infection. Ann. Intern. Med., 121, 847-854.
18. Bernstein, D. I., Lovett, M. A., and Bryson, Y. J. (1984). Serologic analysis of rst-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am. J. Med., 77, 1055-1060.
19. Beyrer, C., Jitwatcharanan, K., Natpratan, C. et al. (1998). Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: Predominance of herpes simplex virus infection. J. Infect. Dis., 178, 243-246.
20. Birch, C., Tyssen, D., Tachedjian, G. et al. (1992). Clinical effects and in vitro studies of triuorothymidine combined with interferon-alpha for treatment of drug-resistant and-sensitive herpes simplex virus infections. J. Infect. Dis., 166, 108-112.
21. Blower, S. and Boe, C. (1993). Sex acts, sex partners, and sex budgets: Implications for risk factor analysis and estimation of HIV transmission probabilitites. J. Acq. Immun. Def. Syndn., 6, 1347-1352.
22. Brice, S., Krzemien, D., Weston, W., and Huff, J. (1989). Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J. Invest. Dermatol., 93, 183-187.
23. Brown, Z. A. (2000). HSV-2 specic serology should be offered rou-tinely to antenatal patients [In Process Citation]. Rev. Med. Virol., 10, 141-144.
24. Brown, Z. A., Selke, S. A., Zeh, J. et al. (1997). Acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med., 337, 509-515.
25. Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., and Corey, L. (2003). Effectofserologicstatusandcesareandeliveryontrans-mission rates of herpes simplex virus from mother to infant. J. Am. Med. Assoc., 289, 203-209.
26. Bryson, Y. J., Dillon, M., Bernstein, D. I., Radolf, J., Zakowski, P., and Garratty, E. (1993). Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: A prospective couple study. J. Infect. Dis., 167, 942-946.
27. Cameron, D. W., Simonsen, J. N., D'Costa, L. J. et al. (1989). Female to male transmission of human immunodeciency virus type 1: Risk factors for seroconversion in men. Lancet, 403-407.
28. Carney, O., Ross, E., Bunker, C., Ikkos, G., and Mindel, A. (1994). A prospective study of the psychological impact on patients with a rst episode of genital herpes. Genitourin. Med., 70, 40-45.
29. Catotti, D. N., Clarke, P., and Catoe, K. E. (1993). Herpes revisited: Still a cause of concern. Sex Transm. Dis., 20, 77-80.
30. Centers for Disease Control and Prevention (2002). Sexually trans-mitted diseases treatment guidelines 2002. MMWR Recomm. Rep., 51, 1-82.
31. Chase, R. A., Pottage, J. C., Jr., Haber, M. H., Kistler, G., Jensen, D., and Levin, S. (1987). Herpes simplex viral hepatitis in adults: Two case reports and review of the literature. Rev. Infect. Dis., 9, 329-333.
32. Chen, C. Y., Ballard, R. C., Beck-Sague, C. M. et al. (2000). Human immunodeciency virus infection and genital ulcer disease in South Africa: The herpetic connection [see comments]. Sex Transm. Dis., 27, 21-29.
33. Chuang, I., Van Beneden, C., Beall, B., and Schuchat, A. (2002). Population-based surveillance for postpartum invasive group A streptococcus infections, 1995-2000. Clin. Infect. Dis., 35, 665-670.
34. Cohen, B., Rowley, A., and Long, C. (1994). Herpes simplex type 2 in a patient with Mollaret's meningitis: Demonstration by polymerase chain reaction. Ann. Neurol., 35, 112-116.
35. Corey, L. and Spear, P. G. (1986). Infections with herpes simplex viruses (part 1). N. Engl. J. Med., 314, 686-691.
36. Corey, L., and Wald, A. (1999). In Sexually Transmitted Diseases, ed. Holmes, K., Sparling, P., PA, M., Lemon, S., Stamm, W., Piot, P., Wasserheit, J. New York: McGraw-Hill.
37. Corey, L., Adams, H. G., Brown, Z. A., and Holmes, K. K. (1983). Clinical course of genital herpes simplex virus infections in men and women. Ann. Intern. Med., 48, 973.
38. Corey, L., Whitley, R. J., Stone, E. F., and Mohan, K. (1988). Differ-ence between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet, 1, 1-4.
39. Corey, L., Wald, A., Celum, C. L., and Quinn, T. C. (2004a). The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J. Acquir. Immune Dec. Syndr., 35, 435-445.
40. Corey, L., Wald, A., Patel, R. et al. (2004b). Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med., 350, 11-20.
41. Darby, G., Field, H., and Salisbury, S. (1981). Altered substrate specicity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature, 289, 81-83.
42. DeJesus, E., Wald, A., Warren, T. et al. (2003). Valacyclovir for the suppression of recurrent genital herpes in human immuno-deciency virus-infected subjects. J. Infect Dis, 188, 1009-1016.
43. Diamond, C., Selke, S., Ashley, R., Benedetti, J., and Corey, L. (1999). Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of rst episode disease. Sex. Transm. Dis., 26, 221-225.
44. Dignani, M. C., Mykietiuk, A., Michelet, M. et al. (2002). Valacyclovir prophylaxis for the prevention of Herpes simplex virus reacti-vation in recipients of progenitor cells transplantation. Bone Marrow Transpl., 29, 263-267.
45. Elion, G., Furman, P., Fyfe, J., deMiranda, P., Beauchamp, L., and Schaeffer, H. (1977). The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl Acad. Sci. USA, 74, 5716-5720.
46. Enders, G., Risse, B., Zauke, M., Bolley, I., and Knotek, F. (1998). Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specic enzyme immunoassay [In Process Citation]. Eur. J. Clin. Microbiol. Infect. Dis., 17, 870-872.
47. Engelberg, R., Carrell, D., Krantz, E., Corey, L., and Wald, A. (2003). Natural history of genital herpes simplex virus type 1 infection. Sex. Transm. Dis., 30, 174-177.
48. Erlich, K., Mills, J., Chatis, P. et al. (1989). Acyclovir-resistant herpes simplex virus infections in patients with the acquired immun-odeciency syndrome. N. Engl. J. Med., 320, 293-296.
49. Evans, A. and Dick, E. (1964). Acute pharyngitis and tonsilitis in University of Wisconsin students. J. Am. Med. Assoc., 190, 699. Fleming, D., McQuillan, G., Johnson, R. et al. (1997). Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med., 337, 1105-1111.
50. Flewett, T., Parker, R., and Philip, W. (1969). Acute hepatitis due to herpes simplex in an adult. J. Clin. Pathol., 22, 60-66.
51. Florman, A. (1973). Intrauterine infection with herpes simplex virus: Resultant congenital malformations. J. Am. Med. Assoc., 225, 129.
52. Frederick, D. M., Bland, D., and Gollin Y. (2002). Fatal disseminated herpes simplex virus infection in a previously healthy pregnant woman. A case report. J Reprod Med., 47, 591-596.
53. Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., and Hayes, R. J. (2006). Herpes simplex virus 2 infec-tion increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS, 20(1), 73-83.
54. Gateley, A., Gander, R., Johnson, P., Kit, S., Otsuka, H., and Kohl, S. (1990). Herpes simplex virus 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J. Infect. Dis., 161, 711-715.
55. Gibbs, R. S., McDufe, R. S., Jr., McNabb, F., Fryer, G. E., Miyoshi, T., and Merenstein, G. (1994). Neonatal group B streptococcal sepsis during 2 years of a universal screening program. Obstet. Gynecol., 84, 496-500.
56. Goyette, R., and Donowho E. (1974). Fulminant hepatitis during pregnancy. Obstet. Gynecol., 43, 191-195.
57. Guex-Crosier, Y., Rochat, C., and Herbort, C. P. (1997). Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul. Immunol. Inamm., 5, 259-265.
58. Gutierrez, K. M., Halpern MSF, Maldonado, Y., and Arvin, A. M. (1999). The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J. Infect. Dis., 180, 199-202.
59. Hashido, M., Kawana, T., Matsunaga, Y., and Inouye S. (1999). Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan. Microbiol. Immunol., 43, 177-180.
60. Herpetic Eye Disease Study Group (1997). A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. Arch. Ophthalmol., 115, 703-712.
61. Hill, T., Blyth, W., and Harbour, D. (1978). Trauma to the skin causes recurrence of herpes simplex in the mouse. J. Gen. Virol., 39, 21-28.
62. Huff, J., Weston, W., and Tonnesen M. (1983). Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes. J. Am. Acad. Dermatol., 6, 763-775.
63. Itoh, N., Matsumura, N., Ogi, A. et al. (2000). High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan. Am. J. Ophthal-mol., 129, 404-405.
64. Kampgen, E., Burg, G., and Wank, R. (1988). Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch. Dermatol., 124, 1372-1375.
65. Keane, J., Malkinson, F., Bryant, J., and Levin, S. (1976). Her-pesvirus hominis hepatitis and disseminated intravascular coagulation: Occurrence in an adult with pemphigus vulgaris. Arch. Dermatol., 93, 1312-1317.
66. Kimberlin, D., Lin C-Y., Jacobs, R. et al. (2001a). Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics, 108, 223-229.
67. Kimberlin, D., Lin, C.-Y., Jacobs, R. et al. (2001b). The safety and efcacy of high-dose acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics, 108, 230-238.
68. Kimberlin, D., Powell, D., Gruber, W., et al. (1996). Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial. Pediatr. Infect. Dis. J., 15, 247-254.
69. Kobberman, T., Clark, L., and Grifn, W. (1980). Maternal death secondary to disseminated herpesvirus hominis. Am. J. Obstet. Gyn., 137, 742-743.
70. Koelle, D. M., Abbo, H., Peck, A., Ziegweld, K., and Corey, L. (1994). Direct recovery of herpes simplex virus (HSV)-specic T lym-phocyte clones from recurrent genital HSV-2 lesions. J. Infect. Dis., 169, 956-961.
71. Koelle, D. M., Reymond, S. N., Chen, H. et al. (2000). Tegument-specic, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J. Virol., 74, 10930-10938.
72. Lafferty, W. E., Coombs, R. W., Benedetti, J., Critchlow, C., and Corey, L. (1987). Recurrences after oral and genital herpes simplex virus infection: Inuence of anatomic site and viral type. N. Engl. J. Med., 316, 1444-1449.
73. Lafferty, W. E., Downey, L., Celum, C., and Wald, A. (2000). Herpes simplex virus type 1 as a cause of genital herpes: Impact on surveillance and prevention. J. Infect. Dis., 181, 1454-1457.
74. Lairson, D. R., Begley, C. E., Reynolds, T. F., and Wilhelmus, K. R. (2003). Prevention of herpes simplex virus eye disease: A cost-effectiveness analysis. Arch. Ophthalmol., 121, 108-112.
75. Lakeman, F. and Whitley, R. (1995). Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cere-brospinal uid from brain-biopsied patients and correlation with disease. J. Infect. Dis., 171, 857-863.
76. Lalezari, J., Schacker, T., Feinberg, J. et al. (1997). A randomized, double-blind, placebo-controlled trial of cidofovir topical gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex infection in patients with AIDS. J. Infect. Dis., 176, 892-898.
77. Langenberg, A., Corey, L., Ashley, R., Leong, W., and Straus, S. (1999). Aprospectivestudyofnewinfectionswithherpessimplexvirus type 1 and type 2. N. Engl. J. Med., 341, 1432-1438.
78. Lemak, M., Duvic, M., Bean, S. (1986). Oral acyclovir for the preven-tion of herpes-associated erythema multiforme. J. Am. Acad. Dermatol., 15, 50-54.
79. Leone, P. A., Trottier, S., and Miller, J. M. (2002). Valacyclovir for episodic treatment of genital herpes: A shorter 3-day treatment course compared with 5-day treatment. Clin. Infect. Dis., 34, 958-962.
80. Liesegang, T. J. (2001). Herpes simplex virus epidemiology and ocu-lar importance. Cornea, 20, 1-13.
81. Linnemann, C., First, M., Alvira, M., Alexander, J., and Schiff, G. (1976). Herpesvirus hominis type 2 meningoencephalitis fol-lowing renal transplantation. Am. J. Med., 61, 703-708.
82. Lowance, D., Neumayer, H. H., Legendre, C. M. et al. (1999). Valacy-clovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N. Engl.J. Med., 340, 1462-1470.
83. Lowhagen, G. B., Tunback, P., Andersson, K., Bergstrom, T., and Johannisson, G. (2000). First episodes of genital herpes in a Swedish STD population: A study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specic serology. Sex. Transm. Infect., 76, 179-182.
84. Luchi, M., Feldman, M., and Williams, W. (1995). Fatal disseminated herpes simplex II infection in a patient with systemic lupus erythematosus. J. Rheumatol. (letter to editors), 22, 799-801.
85. Malkin, J. E., Morand, P., Malvy, D. et al. (2002). Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex. Transm. Infect., 78, 201-203.
86. Malo, A., Kampgen, E., and Wank, R. (1998). Recurrent herpes sim-plexvirus-inducederythemamultiforme: Different HLA-DQB1 alleles associate with severe mucous membrane versus skin attacks. Scand. J. Immunol., 47, 408-411.
87. Manzella, J. P., McConville, J. H., Valenti, W., Menegus, M. A., Swierkosz, E. M., and Arens, M. (1984). An outbreak of her-pes simplex virus type I gingivostomatitis in a dental hygiene practice. J. Am. Med. Assoc., 252, 2019-2022.
88. Mertz, G. J., Coombs, R. W., Ashley, R. et al. (1988). Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: A prospective study. J. Infect. Dis., 157, 1169-1177.
89. Mertz, G. J., Benedetti, J., Ashley, R., Selke, S. A., and Corey, L. (1992). Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med., 116, 197-202.
90. Mertz, G. J., Rosenthal, S. L., and Stanberry, L. R. (2003). Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in rst episodes of genital herpes Sex. Transm. Dis., 30, 801-802.
91. Meyers, J., Flournoy, N., and Thomas, E. (1980). Infection with her-pes simplex virus and cell-mediated immunity after marrow transplant. J. Infect. Dis., 142, 338-346.
92. Mindel, A., Taylor, J., Tideman, R. L. et al. (2000). Neonatal herpes prevention: A minor public health problem in some commu-nities. Sex. Transm. Infect., 76, 287-291.
93. Miura, S., Smith, C., Burnett, J., and Aurelian, L. (1992). Detection of viral DNA within skin of healed recurrent herpes simplex infec-tion and erythema multiforme lesions. J. Invest. Dermatol., 98, 68-72.
94. Morse, S. A., Trees, D. L., Htun, Y. et al. (1997). Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: Association with human immunodeciency virus infection. J. Infect. Dis., 175, 001-007.
95. Ng, P. P., Sun, Y. J., Tan, H. H., and Tan, S. H. (2003). Detection of her-pes simplex virus genomic DNA in various subsets of Erythema multiforme by polymerase chain reaction. Dermatology, 207, 349-353.
96. Niimura, M., and Nishikawa, T. (1988). Treatment of eczema her-peticum with oral acyclovir. Am. J. Med., 85, 49-52.
97. Picard, F., Dekaban, G., Silva, J., and Rice, G. (1993). Mollaret's meningitis associated with herpes simplex type 2 infection. Neurology, 43, 1722-1727.
98. Posavad, C. M., Wald, A., Kuntz, S. et al. (2001). In Conf. Retroviruses Opportunistic Infect., Chicago, IL pp. 211.
99. Prober, C. G., Corey, L., Brown, Z. A. et al. (1992). The management of pregnancies complicated by genital infections with herpes simplex virus. Clin. Infect. Dis., 15, 1031-1038.
100. Puchhammer-Stockl, E., Heinz, F., Kundi, M. et al. (1993). Evalua-tion of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J. Clin. Microbiol., 31, 146-148.
101. Pue, M. A. and Benet, L. Z. (1993). Pharmacokinetics of famciclovir in man. Antiviral Chem. Chemother, 4(S1), 47-55.
102. Quinn, T. C., Corey, L., Chaffee, R. G., Schufer, M. D., Brancato, F. P., and Holmes, K. K. (1981). The etiology of anorectal infection in homosexual men. Am. J. Med., 71, 395-406.
103. Ramsey, P., Fife, K., Hackman, R., Meyers, J., and Corey, L. (1982). Herpes simplex virus pneumonia: Clinical, virologic, and pathologic features in 20 patients. Ann. Intern. Med., 97, 813-820.
104. Reitano, M., Tyring, S., Lang, W. et al. (1998). Valaciclovir for the sup-pression of recurrent genital herpes simplex virus infection: A large-scale dose range-nding study. J. Infect. Dis., 178, 603-610.
105. Reyes, M., Shaik, N. S., Graber, J. M. et al. (2003). Acyclovir-resistant genital herpes among persons attending sexually transmit-ted disease and human immunodeciency virus clinics. Arch. Intern. Med., 163, 76-80.
106. Romanowski, B., Aoki, F. Y., Martel, A. Y., Lavender, E. A., Parsons, J. E., and Saltzman, R. L. (2000). Efcacy and safety of famci-clovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group [In Process Citation]. AIDS, 14, 1211-1217.
107. Rompalo, A., Mertz, G., Davis, L., et al. (1988). Oral acyclovir for treatment of rst-episode herpes simplex virus proctitis. J. Am. Med. Assoc., 259, 2879-2881.
108. Rosenthal, S. L., Stanberry, L. R., Biro, F. M., et al. (1997). Sero-prevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin. Infect. Dis., 24, 135-139. Ross, J. D. C., Smith, I. W., and Elton, R. A. (1993). The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin. Med., 69, 381-383.
109. Safrin, S., Crumpacker, C., Chatis, P., et al. (1991). A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunode-ciency syndrome. N. Engl. J. Med., 325, 551-555.
110. Safrin, S., Elbaggari, A., and Elbeik, T. (1992). Risk factors for the development of acyclovir-resistant herpes simplex virus infec-tion. VII International AIDS Conference 1992; Abstract B. 1548.
111. Safrin, S., Elbeik, T., Phan, L., et al. (1994). Correlation between response to acyclovir and foscarnet therapy and in vitro sus-ceptibility result for isolates of herpes simplex virus from human immunodeciency virus-infected patients. Antimicrob. Agents Chemother, 38, 1246-1250.
112. Schacker, T., Hu, H. L., Koelle, D. M. et al. (1998a). Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Ann. Intern. Med., 128, 21-28.
113. Schacker, T., Zeh, J., Hu, H. L., Hill, J., and Corey, L. (1998b). Fre-quency of symptomatic and asymptomatic HSV-2 reactiva-tions among HIV-infected men. J. Infect. Dis., 178, 1616-1622.
114. Schacker, T. W., Ryncarz, A. J., Goddard, J., Diem, K., Shaughnessy, M., and Corey, L. (1998c). Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. J. Am. Med. Assoc., 280, 61-66.
115. Schrag, S. J., and Schuchat, A. (2004). Easing the burden: Character-izing the disease burden of neonatal group B streptococcal dis-ease to motivate prevention. Clin. Infect. Dis., 38, 1209-1211.
116. Serwadda, D., Gray, R. H., Sewankambo, N. K., et al. (2003). Human immunodeciency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: A nested case-control study in Rakai, Uganda. J. Infect. Dis., 188, 1492-1497.
117. Shefeld, J. S., Hollier, L. M., Hill, J. B., Stuart, G. S., and Wendel, G. D. (2003). Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: A systematic review. Obstet. Gynecol., 102, 1396-1403.
118. Siegal, F., Lopez, C., Hammer, G. et al. (1981). Severe acquired immunodeciency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N. Engl. J. Med., 305, 1439-1444.
119. Smith, J. S., Herrero, R., Munoz, N. et al. (2001). Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines. Sex. Transm. Dis., 28, 187-194.
120. Snoeck, R., Andrei, G., Gerard, M. et al. (1994). Successful treatment of progressive mucocutaneous infection due to acyclovir-and foscarnet-resistant herpes simplex virus with (S)-1(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC). Clin. Infect. Dis., 18, 570-578.
121. Soul-Lawton, J., Seaber, E., On, N., Wootton, R., Rolan, P., and Posner, J. (1995). Absolute bioavailability and metabolic dis-position of valaciclovir, the L-Val ester of acyclovir, following oral administration to humans. Antimicrob Agents Chem., 36, 2759-2764.
122. Souza, P. M., Holland, E. J., and Huang, A. J. (2003). Bilateral herpetic keratoconjunctivitis. Ophthalmology, 110, 493-496.
123. Spruance, S. (1984). Pathogenesis of herpes simplex labialis: Excre-tion of virus in the oral cavity. J. Clin. Microbiol., 19, 675-679.
124. Spruance, S., Overall, J., Kern, E., Krueger, G., Pliam, V., and Miller, W. (1977). The natural history of recurrent herpes simplex labialis: Implications for antiviral therapy. N. Engl. J. Med., 297, 69-75.
125. Spruance, S., Hamill, M., Hoge, W., Davis, L., and Mills, J. (1988). Acyclovir prevents reactivation of herpes simplex labialis in skiers. J. Am. Med. Assoc., 260, 1597-1599.
126. Spruance, S., Freeman, D., Stewart, J. et al. (1991). The natural his-tory of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J. Infect. Dis., 163, 728-734.
127. Spruance, S., Rea, T., Thoming, C., Tucker, R., Saltzman, R., and Boon, R. (1997). Penciclovir cream for the treat-ment of herpes simplex labialis: A randomized, multicenter, double-blind, placebo-controlled trial. J. Am. Med. Assoc., 277, 1374-1379.
128. Spruance, S. L., Jones, T. M., Blatter, M. M. et al. (2003). High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: Results of two randomized, placebo-controlled, multicenter studies. Antimicrob. Agents Chemother., 47, 1072-1080.
129. Stanberry, L. R., Spruance, S. L., Cunningham, A. L. et al. (2002). Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med., 347, 1652-1661.
130. Stern, H., Elek, S., Millar, D., and Anderson, H. (1959). Herpetic whitlow, a form of cross-infection in hospitals. Lancet, 2, 871-874.
131. Sucato, G., Celum, C., Dithmer, D., Ashley, R., and Wald, A. (2001). Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active ado-lescents. Pediatr. Infect. Dis. J., 20, 422-426.
132. Sullivan-Bolyai, J., Hull, H. F., Wilson, C., and Corey, L. (1983). Neonatal herpes simplex virus infection in King County, Washington: Increasing incidence and epidemiological corre-lates. J. Am. Med. Assoc., 250, 3059-3062.
133. Sutton, A., Smithwick, E., Seligman, S., and Kim, D. (1974). Fatal disseminated herpesvirus hominis type 2 infection in an adult with associated thymic dysplasia. Am. J. Med., 56, 545-553.
134. Swanson, J. and Chenitz, W. (1990). Psychosocial aspects of genital herpes: A review of the literature. Pub. Health Nurs., 7, 96-104.
135. Thomas, J., Gangappa, S., Kanangat, S., and Rouse, B. T. (1997). On the essential involvement of neutrophils in the immunopatho-logic disease: Herpetic stromal keratitis. J. Immunol, 158, 1383-1391.
136. Thompson, W., Culbertson, W., Smiddy, W., Robertson, J., and Rosenbaum, J. (1994). Acute retinal necrosis caused by reacti-vation of herpes simplex virus type 2. Am. J. Opthalmol., 118, 205-211.
137. Tookey, P. and Peckham, C. S. (1996). Neonatal herpes simplex virus infection in the British Isles. Paediatr. Perinat. Epidemiol., 10, 432-442.
138. Tran, T. H., Stanescu, D., Caspers-Velu, L. et al. (2004). Clinical char-acteristics of acute HSV-2 retinal necrosis. Am. J. Ophthalmol., 137, 872-879.
139. Varela, J. A., Garcia-Corbeira, P., Aguanell, M. V. et al. (2001). Herpes simplex virus type 2 seroepidemiology in Spain: Prevalence and seroconversion rate among sexually transmitted disease clinic attendees. Sex. Transm. Dis., 28, 47-50.
140. Verjans, G. M., Remeijer, L., Mooy, C. M., and Osterhaus, A. D. (2000). Herpes simplex virus-specic T cells inltrate the cornea of patientswithherpeticstromalkeratitis: Noevidenceforautore-active T cells. Invest. Ophthalmol. Vis. Sci., 41, 2607-2612.
141. Vyse, A. J., Gay, N. J., Slomka, M. J. et al. (2000). The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes. Sex. Transm. Infect., 76, 183-187.
142. Wade, J., Day, L., Crowley, J., and Meyers, J. (1984a). Recurrent infec-tion with herpes simplex virus after marrow transplantation: Role of the specic immune response and acyclovir treatment. J. Infect. Dis., 149, 750-756.
143. Wade, J., Newton, B., Flournoy, N., and Meyers, J. (1984b). Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann. Int. Med., 100, 823-828.
144. Wald, A. and Link, K. (2002). Risk of human immunodeciency virus (HIV) infection in herpes simplex virus type-2 (HSV-2) seropositive persons: A meta-analysis. J. Infect. Dis., 185, 45-52.
145. Wald, A., Corey, L., Cone, R., Hobson, A., Davis, G., and Zeh, J. (1997). Frequent genital HSV-2 shedding in immunocompe-tent women. J. Clin. Invest., 99, 1092-1097.
146. Wald, A., Langenberg, A., Link, K. et al. (2001). Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. J. Am. Med. Assoc., 285, 3100-3106.
147. Wald, A., Carrell, D., Remington, M., Kexel, E., Zeh, J., and Corey, L. (2002a). Two-day regimen of acyclovir for treatment of recur-rent genital herpes simplex virus type 2 infection. Clin. Infect. Dis., 34, 944-948.
148. Wald, A., Zeh, J. E., Selke, S. A., Warren, T., Ashley, R. L., and Corey, L. (2002b). Genital shedding of herpes simplex virus among men. J. Infect. Dis., 186 Suppl 1, S34-S39.
149. Wald, A., Huang, M. L., Carrell, D., Selke, S., and Corey, L. (2003). Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: Comparison with HSV isolation in cell culture. J. Infect. Dis., 188, 1345-1351.
150. Weiss, H., Buve, A., Robinson, N. et al. (2001). The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS, 15 (suppl 4), S97-S108.
151. Wheeler, Jr. C. and Abele, D. (1966). Eczema herpeticum, primary and recurrent. Arch. Dermatol., 93, 162.
152. Whitley, R. (1988). The frustrations of treating herpes simplex virus infections of the central nervous system. J. Am. Med. Assoc., 259, 1067.
153. Whitley, R. J. and Gnann Jr, J. W. (1992). Acyclovir: A decade later. N. Engl. J. Med., 327, 782-789.
154. Whitley, R. and Lakeman, F. (1995). Herpes simplex virus infections of the central nervous system: Therapeutic and diagnostic con-siderations. Clin. Infect. Dis., 20, 414-420.
155. Whitley, R., Nahmias, A., Visintine, A., Fleming, C., and Alford, C. (1980). The natural history of genital herpes simplex virus infection of mother and newborn. Pediatrics, 66, 489.
156. Whitley, R. J., Alford, C. A., Hirsch, M. S. et al. (1986). Vidarabine ver-sus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med., 314, 144-149.
157. Whitley, R., Corey, L., Arvin, A. et al. (1998). Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis., 158, 109-116.
158. Whitley, R., Arvin, A., Prober, C. et al. (1991b). A controlled trial comparing vidarabine with acyclovir in neonatal herpes sim-plex virus infection. N. Engl. J. Med., 324, 444-449.
159. Whitley, R., Arvin, A., Prober, C. et al. (1991b). Predictors of morbid-ity and mortality in neonates with herpes simplex infections. N. Engl. J. Med., 324, 450-454.
160. Whitley, R. J., Kimberlin, D. W., and Roizman, B. (1998). Herpes simplex viruses. Clin. Infect. Dis., 26, 541-553; quiz 554-555.
161. Wilhelmus, K., Beck, R., Moke, P. et al. (1998). Acyclovir for the pre-vention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N. Engl. J. Med., 339, 300-306.
162. Wilkinson, D., Barton, S., and Cowan, F. (2000). HSV-2 specic serol-ogy should not be offered routinely to antenatal patients [In Process Citation]. Rev. Med. Virol., 10, 145-153.
163. Wollenberg, A., Zoch, C., Wetzel, S., Plewig, G., and Przybilla, B. (2003). Predisposing factors and clinical features of eczema herpeticum: A retrospective analysis of 100 cases. J. Am. Acad. Dermatol., 49, 198-205.
164. Xu, F., Schillinger, J. A., Sternberg, M. R. et al. (2002). Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J. Infect. Dis., 185, 1019-1024.
165. Yamamoto, L., Tedder, D., Ashley, R., and Levin, M. (1991). Her-pes simplex virus type 1 DNA in cerebrospinal uid of a patient with Mollaret's meningitis. N. Engl. J. Med., 325, 1082-1085.
166. Yoshida, M. and Amatsu, A. (2000). Asymptomatic shedding of her-pes simplex virus into the oral cavity of patients with atopic dermatitis. J. Clin. Virol., 16, 65-69.